Bovie Medical Corporation to Participate in Barrington Research Investment Conference

CLEARWATER, Fla.--()--Bovie Medical Corporation (“Bovie” or the “Company”) (NYSE:BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, announced today that Robert L. Gershon, Chief Executive Officer of the Company, will participate in the Barrington Research 8th Annual Fall Investment Conference.

The conference will be held at the Four Seasons Hotel in Chicago, and Mr. Gershon will present to investors on September 1, 2015. Investors attending may arrange a one-on-one meeting by contacting Barrington Research.

About Bovie Medical Corporation

Bovie Medical Corporation is a leading maker of medical devices and supplies as well as the developer of J-Plasma®, a patented new plasma-based surgical product for cutting and coagulation. J-Plasma® utilizes a helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery. Bovie Medical Corporation is also a leader in the manufacture of a range of electrosurgical products and technologies, marketed through both private labels and the Company’s own well-respected brands (Bovie®, Aaron®, IDS™ and ICON™) to distributors worldwide. The Company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company’s current and new products, please refer to the Investor Relations section of Bovie Medical Corporation’s website www.boviemed.com.

Contacts

Investor Relations
MBS Value Partners
Hugh Collins, (212) 223-4632
investor.relations@boviemed.com

Recent Stories

RSS feed for Bovie Medical Corporation

Bovie Medical Corporation